Dr Frederic G. Reamer joins Ethics Talk to discuss his article: “Why Care-Based, Not Carceral, Approaches to Suspects With Mental Illness Is Key to Whether We Trust Professional or State Authority Ever Again”
The pharmaceutical industry's influence on the process of defining illness can be positive, as when drug companies increase public awareness of disease and develop effective therapies, or negative, if it pushes the boundaries of illness too far in pursuit of profit.